Maternal genome-wide DNA methylation patterns and congenital heart defects

• Published in: PloS one Vol. 6; no. 1; p. e16506
• Main Authors: Chowdhury, Shimul, Erickson, Stephen W, MacLeod, Stewart L, Cleves, Mario A, Hu, Ping, Karim, Mohammad A, Hobbs, Charlotte A
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 24.01.2011; Public Library of Science (PLoS)
• Subjects: Analysis; Biological activity; Biology; Birth defects; Case-Control Studies; Children & youth; Congenital diseases; Congenital heart defects; CpG Islands; Defects; Deoxyribonucleic acid; Developmental biology; Diet; DNA; DNA Methylation; Environmental factors; Epigenetic inheritance; Epigenetics; Female; Fetal development; Fetal Development - genetics; Fetuses; Gene set enrichment analysis; Genes; Genetic aspects; Genetic disorders; Genetic research; Genome, Human - genetics; Genome-Wide Association Study; Genomes; Genomics; Heart; Heart Defects, Congenital - epidemiology; Heart Defects, Congenital - genetics; Hospitals; Humans; Lymphocytes; Mathematical models; Medical research; Medicine; Methylation; Mothers; Organogenesis; Pediatrics; Peripheral blood; Population; Population (statistical); Population studies; Pregnancy; Public health; Studies; United States > US; Arkansas
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0016506

The majority of congenital heart defects (CHDs) are thought to result from the interaction between multiple genetic, epigenetic, environmental, and lifestyle factors. Epigenetic mechanisms are attractive targets in the study of complex diseases because they may be altered by environmental factors and dietary interventions. We conducted a population based, case-control study of genome-wide maternal DNA methylation to determine if alterations in gene-specific methylation were associated with CHDs. Using the Illumina Infinium Human Methylation27 BeadChip, we assessed maternal gene-specific methylation in over 27,000 CpG sites from DNA isolated from peripheral blood lymphocytes. Our study sample included 180 mothers with non-syndromic CHD-affected pregnancies (cases) and 187 mothers with unaffected pregnancies (controls). Using a multi-factorial statistical model, we observed differential methylation between cases and controls at multiple CpG sites, although no CpG site reached the most stringent level of genome-wide statistical significance. The majority of differentially methylated CpG sites were hypermethylated in cases and located within CpG islands. Gene Set Enrichment Analysis (GSEA) revealed that the genes of interest were enriched in multiple biological processes involved in fetal development. Associations with canonical pathways previously shown to be involved in fetal organogenesis were also observed. We present preliminary evidence that alterations in maternal DNA methylation may be associated with CHDs. Our results suggest that further studies involving maternal epigenetic patterns and CHDs are warranted. Multiple candidate processes and pathways for future study have been identified.